Skip to main content
Logo icon
Conservative Foreign and
Commonwealth Council

Main navigation

  • About us
  • Key People
  • Get involved
  • News
  • Events
  • Contact
Logo icon
Conservative Foreign and
Commonwealth Council

“Sickle Cell Disease and Thalassaemia: past, present and future” Dr Lambros Bourantas, Consultant in Haematology, Imperial College Healthcare NHS Trust

  • Tweet
Wednesday, 28 July, 2021
  • Reports
Lambros
L Chalker
Hooper
Ranger
Buckwell 2807
R Barry 28 07
William Knight 28 07
P Marshall
DT

The recording of this meeting is here.

 

Dr Lambros Bourantas

Education:

Medical School             National University of Athens,School of Medicine, Athens, Greece.

School                            4th High School of Ioannina, Ioannina, Greece.

Qualifications

CCST equivalent in Haematology   Athens, Greece, 2014

Doctor of Sciences degree             Department of Obstetrics and Gynecology,

(PhD)                                              Univ. Hospital of Ioannina, Greece, 2008

Degree of Medicine                       University of Athens, Greece, 2003

(Ptychio Iatrikes)                              

Membership of Societies:

  • General Medical Council, UK, Full Registration (Reg. Nο 609 3925)
  • Royal College of Physicians, UK
  • Hellenic Society of Haematology, Greece
  • Médecins du Monde, Greece

Current Appointments

        Post                       Institution                                      Dates

Locum                      Department of Haematology,          7th Jan 2019-presen

Consultant                Imperial College Healthcare

in Haematology,        NHS Trust, London, UK

NHS Trust post

Scientific collaborator,   European University          September 2017-present        

Haematology                   of Cyprus

Course Co-ordinator           

Previous Appointments                                  

Locum Consultant in Haematology, November 2015 to December 2018       

Lister Hospital, ENH NHS Trust

Tameside Hospital, Manchester

Bedford Hospital

Diana Princes of Wales Hospital, North Lincolnshire & Goole NHS Foundation Trust

Training in Internal Medicine/Haematology

Hematology           Department of Haematology,            Jan 2012-June 2014

SpR,                      Hammersmith Hospital,

Clinical Fellow       Imperial College, NHS Trust,

                             London, UK

Hematology           Department of Haematology,              Mar 2009-Dec 2011

Fellow in               University Hospital of Ioannina,

Haematology         Greece                          

Clinical                 401 Military Hospital of                     May 2007-Feb 2009

Fellow                   Athens, Greece 

Internal Medicine

Awards and Prizes

Poster Award: E. Hatzimichael, L.K. Bourantas,  M. Bai, S. Kamina, P. Kanavaros,  N.I. Agnanti, K. L. Bourantas. Investigation of transfers of the MML gene in patients with myelodysplastic syndromes using Florescence in Situ Hybridisation (FISH). 2nd Panepirotic Medical Congress, Ioannina, Greece, 10-12 October, 2002.

Publications in International Journals

  • A Fatal Case of Chronic Active EBV infection. Mehta D, Deplano S, Olavarria E, Gaur P, Bourantas L. Annals of Hematology and Oncology (accepted, awaiting publication)
  • Immune Thombocytopenia: a review in diagnosis and treatment, and

         update in managementduring COVID19 pandemic. Kelly Magounaki,  

         L.K. Bourantas. Acta Haematologica (accepted, awaiting publication)

  • Daraki A, L.K. Bourantas, Manola KN. Translocation t(5;18)(q35;q21) as a rare nonrandom abnormality in acute myeloid leukemia. Cytogenet Genome Res. 2013;139(4):289-9
  • L.K. Bourantas, Pappas G, Kapsali E, Gougopoulou D, Papamichail D, Bourantas KL. Brucellosis-induced autoimmune haemolytic anemia treated with rituximab. Ann Pharmacother. 2010 Oct;44(10):1677-80.
  • Tsiara SN, Chaidos A, L.K. Bourantas, Kapsali HD, Bourantas KL. Recombinant human erythropoietin for the treatment of anemia in patients with chronic idiopathic myelofibrosis. Acta Hematol 2007; 117(3):156-61.
  • L.K. Bourantas, Chatzikyriakidou A, Dassoula A, Syrou M,  Bourantas KL,Georgiou I. Absence of mutations of the EPO-receptor gene in Greek patients with familiar polycythemia. Eur. J. Haematol. 2006 Jun;76(6):537-8.

Presentations-Lectures World-wide

  • L.K. Bourantas Diagnosis and management of HLH Guidelines. Haematology Department, Hammersmith Hospital, London, UK. 28th October 2020.
  • L.K. Bourantas Investigation of Anemia. Haematology Department, Hammersmith Hospital, London, UK. 19th August 2020.
  • L.K. Bourantas Investigation of Anemia. Haematology Department, Hammersmith Hospital, London, UK. 1st October 2020.
  • L.K. Bourantas Management of Sickle Cell Disease. Lister Hospital, East and North Hertfordshire NHS Trust, UK. 16th May 2017.
  • L.K. Bourantas Actual management of acute and chronic Graft-versus-Host disease. Hospital de Especialidades Puebla, Mexico. 7th August 2009.
  • L.K. Bourantas: Post Transplant Lymphoproliferative Disorders. Commonwealth Building, Hammersmith Hospital, London. UK. 8th July 2005.

International Congresses-Posters 

S. J. Theodorou, D. J. Theodorou, L.K. Bourantas, M. Mastora, V. Kaloutsi, N. Akritidis, K. Gossios, E. Briassoulis, K. Tsiabouras. Primary bone lymphoma : imaging manistefations of haematological malignancy with pathologic correlation. Annual joint radiological congres. Manchester, UK, 25-27 June 2012.

L.K. Bourantas, A. Chatzikyriakidou, K. Panteli, M. Bai, D.K. Bourantas, St. Tsiara, I. Georgiou, K.L. Bourantas. JAK2 V617F mutation and VEGF levels in patients with myeloproliferative disorders. 12th Congress of the European Hematology Association. Vienna, Austria, 7-10 June 2007.

E. Hatzimichael, A. Vassou, L. Benetatos,, L.Κ. Bourantas, St. Tsiara, E. Kapsali, K.L. Bourantas, Safety and efficacy of a combination regimen containing pentostatin, chloramucil and methylprednisolone in elderly patients with progressing chronic lymphocytic leukemia. 11th Congress of the European Hematology Association, Amsterdam, the Netherlands, 15-1June, 2006.

L.Κ. Bourantas, A. Chatzikyriakidou, A. Dasoula, E. Hatzimichael, St. Tsiara, M. Syrrou, K.L. Bourantas. I. Georgiou. Epo-R mutations in familial congenital polycythemia vera. 11th Congress of the European Hematology Association, Amsterdam, the Netherlands, 15-18 June, 2006.

K. Panteli, M. Bai, N. Zagorianakou, L.K. Bourantas, E. Hatzimichael, K.L. Bourantas. VEGF serum levels and VEGF bone marrow immunohistochemical expression in chromic myeloproliferative disorders. 11th Congress of the European Hematology Association, Amsterdam, the Netherlands, 15-18 June, 2006.

M. Gouva, D. Damigos, A. Katsouda, P. Karamanos, P. Bouranta, L.K. Bourantas, A. Chaidos, V. Alymara, A. Vassou, V. Mavreas, K.L. Bourantas. Anxiety in Acute Leukemia. Balkan Conference of young scientists. Plovdiv, Bulgaria, 16-18 June, 2005.

K. L. Bourantas, St. Tsiara, V. Alymara, A, Chaidos, E. Kapsali, K. Papanikoaou, L.K. Bourantas, L. Christou, E. Tzouvara. Treatment of anemia in idiopathic myelofibrosis using erythropoietin. 7th Meeting of the European Hematology Association. Florence, Italy, 6-9 June, 2002.

You may also be interested in

as

'The Foreign Office: when did the Foreign Secretary lose power to No. 10' With Sir Anthony Seldon, Historian, Author, Educator

Sunday, 1 June, 2025
 ‘Members of the  Conservative Foreign & Commonwealth Council (CFCC) attended a talk at the House of Lords on Monday the 19th May  by Sir Anthony Seldon, the acknowledged  national authority on all matters relating to Number 10 and British prime ministers.Sir Anthony was

Show only

  • Articles
  • Local News
  • Media
  • Reports

Conservative Foreign and Commonwealth Council

Footer

  • About RSS
  • Accessibility
  • Cookies
  • Privacy
  • About Us
  • Get involved
ConservativesThis website is published and paid for by the Conservative Foreign & Commonwealth Council (CFCC) on its own behalf.
Copyright 2025 Conservative Foreign and Commonwealth Council . All rights reserved.
Powered by Bluetree